The study found that semaglutide and tirzepatide, drugs widely prescribed for diabetes and obesity, were linked to lower RA disease activity, reduced pain, and better metabolic outcomes compared with patients who did not use them
Our pharmacy helped us do that as we prepared to design this trial
As it focuses on fat metabolism, it doesnt alter hormone levels compared to others
Zepbound fue el segundo nombre comercial que Lilly puso a la tirzepatida, el compuesto con el que Lilly se lanz a competir contra la diabetes tipo 2, como Ozempic
Which GLP-1 agonists are available on the NHS for weight management
What new players are doing differently This fast-shifting regulatory picture has galvanised companies that see an emerging sector with tremendous potential for growth